SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 140 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q2 2018. The put-call ratio across all filers is 1.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $229,000 | -54.4% | 125,000 | -44.4% | 0.01% | -44.4% |
| Q4 2017 | $502,000 | -23.1% | 225,000 | 0.0% | 0.01% | -30.8% |
| Q3 2017 | $653,000 | -34.8% | 225,000 | 0.0% | 0.01% | -58.1% |
| Q2 2017 | $1,001,000 | -4.6% | 225,000 | 0.0% | 0.03% | +10.7% |
| Q1 2017 | $1,049,000 | -72.2% | 225,000 | -66.2% | 0.03% | -76.1% |
| Q4 2015 | $3,771,000 | +216.1% | 665,000 | +195.6% | 0.12% | +108.9% |
| Q3 2015 | $1,193,000 | -55.8% | 225,000 | -30.8% | 0.06% | -3.4% |
| Q2 2015 | $2,698,000 | – | 325,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 2,200,000 | $6,072,000 | 2.38% |
| GREAT POINT PARTNERS LLC | 2,175,000 | $6,003,000 | 2.15% |
| Belmont Global Advisors, Inc. | 400,000 | $1,104,000 | 1.12% |
| Trellus Management Company, LLC | 162,900 | $450,000 | 0.78% |
| PURA VIDA INVESTMENTS, LLC | 572,800 | $1,581,000 | 0.72% |
| DAFNA Capital Management LLC | 294,563 | $813,000 | 0.70% |
| Twin Securities, Inc. | 1,687,115 | $4,656,000 | 0.58% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 1,000,000 | $2,760,000 | 0.33% |
| WALL STREET ASSOCIATES | 269,300 | $743,000 | 0.31% |
| Paulson & Co. | 11,090,000 | $30,608,000 | 0.23% |